CollPlant Biotechnologies Ltd. (CLGN)

NASDAQ: CLGN · IEX Real-Time Price · USD

4.863

-0.087 (-1.76%)

At close: Jul 19, 2024, 4:00 PM

4.950

+0.087 (1.79%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

CollPlant Biotechnologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Net Income	-7.5	-7.02	-16.93	0.24	-5.77	-11.16	Upgrade
Depreciation & Amortization	1.1	1.1	1.08	0.77	0.66	0.54	Upgrade
Share-Based Compensation	1.71	1.94	2.17	1.6	1.67	1.13	Upgrade
Other Operating Activities	2.12	1.22	-0.02	-0.11	-1.01	3.8	Upgrade
Operating Cash Flow	-2.57	-2.76	-13.7	2.5	-4.45	-5.7	Upgrade
Capital Expenditures	-0.82	-0.89	-1.32	-1.56	-0.52	-1.46	Upgrade
Change in Investments	-	-0.27	30.24	-30	0	0	Upgrade
Other Investing Activities	-0.27	-	-	-	-	-	Upgrade
Investing Cash Flow	-1.09	-1.16	28.92	-31.56	-0.52	-1.46	Upgrade
Share Issuance / Repurchase	0.31	1.11	1.87	38.76	4.49	5.45	Upgrade
Debt Issued / Paid	-	-	0	0	-0.02	-0.04	Upgrade
Financing Cash Flow	0.31	1.11	1.87	38.76	4.47	5.41	Upgrade
Exchange Rate Effect	-0.22	-0.38	-0.61	0.14	0.06	-0.06	Upgrade
Net Cash Flow	-3.72	-3.19	16.49	9.85	-0.51	-1.75	Upgrade
Free Cash Flow	-3.39	-3.65	-15.01	0.95	-4.97	-7.16	Upgrade
Free Cash Flow Margin	-31.90%	-33.30%	-5021.40%	6.04%	-80.98%	-309.06%	Upgrade
Free Cash Flow Per Share	-0.30	-0.32	-1.36	0.10	-0.72	-1.44	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).